Wearable to Remotely Track Vital Signs for COVID-19

大多数COVID-19检测呈阳性的人被送回家中并自我隔离。2%-8%的COVID-19患者出现导致死亡的严重反应。目前，公共卫生工作者通过一对一的方式跟踪COVID-19患者的病情进展。更广泛地追踪病例是降低病死率的必要途径。随着COVID-19患者人数的增加，这种方法变得不可持续。为了消除这种方法，拟议的项目旨在设计、开发和评估一种低成本（<20美元）且易于使用的集成了多传感器平台的腕带。这款腕带可以持续远程测量患者的位置和生命体征，如血氧饱和度、心率和呼吸率、血压和体温。测量的生命体征和位置数据将上传到网络（云）上。如果任何生理参数显示出风险，该网络将向医疗保健专业人员发出警报。医疗保健专业人员将能够实时监测患者的生命体征，并检查患者的病情进展。因此，医疗保健专业人员将能够根据远程接收到的数据和警报为患者采取行动，而不是一对一的呼叫。在加拿大，通过远程监测老年人的生命体征并及时为他们提供护理，可以大大减少老年护理院的很大一部分伤亡。在这方面，提出的低成本追踪腕带是一个可行和有效的解决方案，以支持加拿大的医疗保健系统。在隐私方面，收集用户数据前需要征得用户的同意。项目完成后，iMD研究中心将迅速部署跟踪腕带，用于患者监测。最初，他们将在蒙特利尔当地的老年护理院部署大约1000台设备。随后，他们将与当地卫生部门合作，在家中追踪患者。加拿大恢复正常生活的能力将取决于测试、追踪和追踪的能力。我们提出的解决方案可以在未来几天的测试、跟踪和跟踪工作中提供巨大的帮助。

Most of those who test positive for COVID-19 are sent back home and self-confine. Between 2%-8% of COVID-19 patients have severe responses that lead to death. Currently, public health workers track the progression of the illness for the COVID-19 patients by calling them 1-by-1. Tracking the cases more widely is an indispensable approach to minimize the morality rate. As the number COVID-19 patients is increasing, this approach becomes unsustainable. To eliminate this approach, the proposed project aims to design, develop and evaluate a low cost (<20$) and easy to use wristband integrating a multi sensor platform. The wristband will allow continuous remote measurement of patient's location and vital signs such as blood oxygen saturation, heart and respiration rate, blood pressure and temperature. The measured vital signs and location data will be uploaded on a network (cloud). The network will send alerts to health care professionals if any physiological parameter shows risk. Health care professionals will be able monitor patient's real time vital signs and check the patient's progression of illness. Thus, instead of calling 1-by-1, health care professionals will be able take action for patients based on the data and alerts received remotely. In Canada a large fraction of the casualties in senior care homes can be significantly reduced by remotely monitoring vital signs of seniors and bringing care to them on time. In this regard, the proposed low cost tracker wristband is a feasible and effective solution to support the Canadian health care system. Regarding privacy, consent of the user needs be taken before collecting their data. After completion of the project, iMD Research will quickly move to deploy the tracker wristband for patient monitoring. Initially, they will deploy approximately 1000 devices in local senior care homes in Montreal. Later they will make partnership will local health authorities to track patients at home. The ability of Canada to go back to normal life will depend on the competence to test, trace and track. Our proposed solution can be of immense assist in that effort of test, trace and track in the coming days.